Skip to content
10-Q

Quarterly Report

Icagen, Inc.

0001213900-18-011474

← back to feed
Filed
Aug 20, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Aug 20, 2018 6.39M sh
Current Liabilities Q2 2018 · Jun 30, 2018 $6.46M
Current Liabilities Q2 2018 · Dec 31, 2017 $4.97M
Total Liabilities Q2 2018 · Jun 30, 2018 $27.94M
Total Liabilities Q2 2018 · Dec 31, 2017 $23.31M
Current Assets Q2 2018 · Jun 30, 2018 $3.69M
Current Assets Q2 2018 · Dec 31, 2017 $4.79M
Total Assets Q2 2018 · Jun 30, 2018 $13M
Total Assets Q2 2018 · Dec 31, 2017 $14.64M
Net Income Q2 2018 · Dec 31, 2017 −$6.11M
Net Income Q2 2018 · Jun 30, 2017 −$1.92M
Net Income Q2 2018 · Jun 30, 2017 −$2.72M
Capex Q2 2018 · Jun 30, 2017 $555.13K
Operating Cash Flow Q2 2018 · Jun 30, 2017 −$7.8M
Cash And Equivalents Q2 2018 · Jun 30, 2017 $5.8M
Cash And Equivalents Q2 2018 · Dec 31, 2016 $4.94M
Sga Expense Q2 2018 · Jun 30, 2017 $3.81M
Sga Expense Q2 2018 · Jun 30, 2017 $6.91M
Operating Income Q2 2018 · Jun 30, 2017 −$1.64M
Operating Income Q2 2018 · Jun 30, 2017 −$2.3M
Gross Profit Q2 2018 · Jun 30, 2017 $2.69M
Gross Profit Q2 2018 · Jun 30, 2017 $5.57M
Revenue Q2 2018 · Jun 30, 2017 $5.77M
Revenue Q2 2018 · Jun 30, 2017 $11.59M